Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in Women With Primary Infertility

Safety and Efficacy of Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in Women With Primary Infertility

We aim to assess the Safety and Efficacy of Cervical Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in women with primary infertility

We aim to assess the Safety and Efficacy of Cervical Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in Women with Primary Infertility.

Inclusion Criteria:

• Women aged 18-45 years. Diagnosed with primary infertility (no prior pregnancy after at least 12 months of unprotected intercourse) and scheduled for HSG as part of infertility evaluation.

Exclusion Criteria:

• Known allergy or hypersensitivity to lidocaine, prilocaine, or any components of the spray.
• Current pregnancy or suspicion of pregnancy.
• Active pelvic inflammatory disease or history of severe pelvic infections within the last 6 months.
• Use of systemic analgesics, sedatives, or anesthetics within 24 hours prior to the procedure.